This organization files Form 990, which has no section for application policy. Its filings cannot say either way.
The latest filing we hold carries no statement about applications. That is not the same as closed: public-charity Form 990s have no field for it, and many foundations leave the section blank.
Grants paid by year
Total assets by year
Where the money went · FY2024
Form 990 splits expenses into program services, management and fundraising. The split is self-reported, and a grantmaker, a research institute and a direct-service nonprofit book the same work differently. A line the return does not carry reads "not available"; it is never counted as zero.
| Year | Form | Revenue | Expenses | Grants paid | Assets | Net assets |
|---|---|---|---|---|---|---|
| FY2024 | 990 | $5,427,037 | $16,040,341 | $0 | $23,694,605 | −$2,719,021 |
| FY2023 | 990 | $5,040,198 | $15,033,401 | $0 | $18,815,048 | $7,894,283 |
| FY2022 | 990 | $5,012,409 | $13,721,023 | $0 | $21,827,142 | $7,034,087 |
| FY2021 | 990 | $3,990,807 | $10,638,729 | $0 | $16,636,977 | $6,246,906 |
| FY2020 | 990 | $11,678,298 | $21,889,542 | $0 | $25,453,948 | −$36,928,435 |
Figures are as reported on the e-filed return, with no restatement. Fiscal years are the funder's own tax year, labelled by the calendar year the period ends in. A blank line means the return does not carry that figure; a real zero shows as $0. When an amended return replaces an original, every figure here uses the amended return. The original is not shown. Giving is what the funder actually paid out toward its charitable purpose in the year (qualifying distributions on Form 990-PF, charitable disbursements otherwise). Assets are what it holds; giving is what moves.
No grant rows from public filings are on record for this funder. Grant lists come from Form 990-PF and from Schedule I of Form 990; a return the IRS has not yet published, or one with no grant list, has no rows here.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Biobridge Global | SOLE MEMBER | 1.0 | $0 |
| Geoffrey Kindt | General Manager, Biomanufacturing (thru 11/02/2024) | 50.0 | $260,606 |
| Amanda Whitelonis | Principal Global Market Development (effective 11/03/2024) | 50.0 | $20,119 |
| Mari Lane Salmi | SR. DIRECTOR, PROCESS DEV & CELL THERAPIES |
From the officer list on the latest e-filed return. Compensation is as reported there; a blank means the return carries no figure.
| 50.0 |
| $203,361 |
| Miguel Garza | Director, Operations Biomanufacturing | 50.0 | $156,301 |
| Milton Masayuki Pollard | VP, GENCURE OPERATIONS (thru 07/09/2024) | 50.0 | $196,274 |
| Rogelio Zamilpa | Executive Director, Biomanufacturing & Collab | 50.0 | $215,099 |
Form 990 · FY2023 · period ending Dec 31, 2023IRS bulk XML
Filing id 202403199349319060
Form 990 · FY2022 · period ending Dec 31, 2022
Filing id 202333199349314038
Form 990 · FY2021 · period ending Dec 31, 2021
Filing id 202203199349304610
Form 990 · FY2020 · period ending Dec 31, 2020
Filing id 202113199349322521
Form 990 · FY2019 · period ending Dec 31, 2019
Filing id 202023219349300142
Form 990 · FY2018 · period ending Dec 31, 2018
Filing id 201923199349310967
Form 990 · FY2017 · period ending Dec 31, 2017
Filing id 201813189349305776
Form 990 · FY2016 · period ending Dec 31, 2016
Filing id 201733189349307533
Form 990 · FY2015 · period ending Dec 31, 2015
Filing id 201643209349315874
IRS filings are the source for every fact on this page. Nothing a model writes is ever a source; it can only point at a row here.